Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri and Reduced Plaque Index

Research synthesisLow evidenceMixed effect size3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial effects of Lactobacillus reuteri on reducing Plaque Index, with effect sizes ranging from small to moderate; 1 study found no additional benefit over placebo. The median study duration was 180 days (1 study). Populations studied included adolescents with betel quid chewing habits and diabetic adults with periodontitis. The evidence base is small, and findings should be considered preliminary.

  • Effective dose range: one lozenge daily to twice a day for 14 days
  • Studied populations: adolescents (aged 12-15) with betel quid chewing habits; diabetic adults with periodontitis

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. The single highest-quality study (evidence score 5) found no significant effect, contrasting with two lower-quality studies showing benefit. Dosing and duration varied widely across studies, and no form data was reported.

Generated Jun 9, 2026
Doses used in studies
  • day: 2 (median 2, IQR 22) 1 study
  • lozenge/day: 1 (median 1, IQR 11) 1 study
Time to effect
Median: 6 months · IQR 6 months6 months · Range 6 months6 months — Reported in 1 of 3 studies
3 of 3 papers
Back to top